Factor VIIa-induced p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain

被引:105
作者
Sorensen, BB
Freskgård, PO
Nielsen, LS
Rao, LVM
Ezban, M
Petersen, LC
机构
[1] Novo Nordisk AS, Hlth Care Discovery, Tissue Factor Factor VII Res, DK-2760 Malov, Denmark
[2] Univ Texas, Ctr Hlth, Dept Biochem, Tyler, TX 75710 USA
关键词
D O I
10.1074/jbc.274.30.21349
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Signal transduction induced by activated factor VII (FVIIa) was studied with baby hamster kidney (BHK) cells transfected with human tissue factor (TF), FVIIa induced phosphorylation of p44/42 mitogen-activated protein kinase (MAPK) in cells expressing TF, BHK(+TF), but not in wild-type BHK(-TF) cells. BHK(+TF) cells responded to FVIIa in a dose-dependent manner, with detectable phosphorylation above 10-20 nM FVIIa. BHK cells transfected with a cytoplasmic domain-deleted version of TF, (des248-263)TF, or a C245S substitution variant of TF also supported FVIIa-induced MAPK activation. Experiments with active site-inhibited FVIIa, thrombin, factor Xa, and hirudin confirmed that the catalytic activity of FVIIa was mandatory for p44/42 MAPK activation. Furthermore, a high concentration of FVIIa in complex with soluble TF induced p44/42 MAPK phosphorylation in BHK(-TF) cells. These data suggest that TF was not directly involved in FVIIa-induced p44/42 MAPK phosphorylation but rather served to localize the action of FVIIa to the cell surface, potentially to cleave a cell surface receptor. Desensitization experiments with sequential addition of proteases suggested that the p44/42 MAPK response induced by FVIIa was distinctly different from the thrombin response, possibly involving a novel member of the protease-activated receptor family.
引用
收藏
页码:21349 / 21354
页数:6
相关论文
共 37 条
[31]   Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor [J].
Sorensen, BB ;
Persson, E ;
Freskgard, PO ;
Kjalke, M ;
Ezban, M ;
Williams, T ;
Rao, LVM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (18) :11863-11868
[32]  
Taniguchi T, 1998, CANCER RES, V58, P4461
[33]  
Taubman MB, 1997, THROMB HAEMOSTASIS, V78, P200
[34]   AMINO-ACID SEQUENCE AND POSTTRANSLATIONAL MODIFICATIONS OF HUMAN FACTOR-VIIA FROM PLASMA AND TRANSFECTED BABY HAMSTER-KIDNEY CELLS [J].
THIM, L ;
BJOERN, S ;
CHRISTENSEN, M ;
NICOLAISEN, EM ;
LUNDHANSEN, T ;
PEDERSEN, AH ;
HEDNER, U .
BIOCHEMISTRY, 1988, 27 (20) :7785-7793
[35]   MOLECULAR-CLONING OF A FUNCTIONAL THROMBIN RECEPTOR REVEALS A NOVEL PROTEOLYTIC MECHANISM OF RECEPTOR ACTIVATION [J].
VU, TKH ;
HUNG, DT ;
WHEATON, VI ;
COUGHLIN, SR .
CELL, 1991, 64 (06) :1057-1068
[36]   Cloning and characterization of human protease-activated receptor 4 [J].
Xu, WF ;
Andersen, H ;
Whitmore, TE ;
Presnell, SR ;
Yee, DP ;
Ching, A ;
Gilbert, T ;
Davie, EW ;
Foster, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) :6642-6646
[37]  
ZINOCHECK TF, 1992, J BIOL CHEM, V267, P3561